Entecavir Tablets, USP, 0.5 mg, 30 Tablets, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ah...

FDA Recall #D-0656-2025 — Class II — September 4, 2025

Recall #D-0656-2025 Date: September 4, 2025 Classification: Class II Status: Ongoing

Product Description

Entecavir Tablets, USP, 0.5 mg, 30 Tablets, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-920-06.

Reason for Recall

Failed Impurity/Degradation Specifications

Recalling Firm

Zydus Pharmaceuticals (USA) Inc — Pennington, NJ

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

4344 bottles

Distribution

U.S. Nationwide

Code Information

Lot E309376; Exp 11/30/2025

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated